Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)

Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)

Background The efficacy and safety of rivaroxaban have been demonstrated in phase 3 trials of patients with venous thromboembolism (VTE; pulmonary embolism [PE] and deep vein thrombosis [DVT]). Data regarding rivaroxaban treatment of VTE in routine Japanese clinical practice remain limited....

Full description

Bibliographic Details
Main Authors: Ikuo Fukuda, Atsushi Hirayama, Kazuo Kawasugi, Takao Kobayashi, Hideaki Maeda, Mashio Nakamura, Norifumi Nakanishi, Norikazu Yamada, Tsubasa Tajima, Sanghun Iwashiro, Yutaka Okayama, Toshiyuki Sunaya, Kazufumi Hirano, Takanori Hayasaki
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2021-10-01
Series:TH Open
Subjects:
japan
pulmonary embolism
rivaroxaban
venous thromboembolism
venous thrombosis
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-1664-1164

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/a-1664-1164

Similar Items